Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H28O2 |
Molecular Weight | 312.4458 |
Optical Activity | ( + ) |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12CC[C@](O)(C#C)[C@]1(CC)CC[C@@]3([H])[C@]4([H])CCC(=O)C=C4CC[C@]23[H]
InChI
InChIKey=WWYNJERNGUHSAO-XHCJJCCMSA-N
InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23H,3,5-12H2,1H3/t16-,17+,18+,19-,20-,21-/m1/s1
Molecular Formula | C21H28O2 |
Molecular Weight | 312.4458 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Norgestrel,(+) (dextronorgestrel) is the biologically inactive isomer of norgestrel. Dextronorgestrel showed no ability to displace labelled levonorgestrel from the sex hormone binding globulin sites. In vitro active form being converted mainly to the 16 beta-hydroxysteroid and inactive form to the 16 alpha-hydroxysteroid. There was practically no binding to dextronorgestrel of dextronorgestrel to a cytoplasmic receptor prepared from the myometrium of estrogenized immature female rabbits was investigated. While some medications may contain dextronorgestrel, they are often labeled in terms of their levonorgestrel content only, ignoring the inert isomer.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Metabolism of D- and L-norgestrel in humans. | 1975 Jun |
|
The presence of dl-, d- and l-norgestrel and their metabolites in the plasma of women. | 1975 Sep |
|
Binding of the contraceptive steroids norgestrel and norethisterone in human plasma. | 1980 May |
|
Quantitative approach for the screening of cyclodextrins by nuclear magnetic resonance spectroscopy in support of chiral separations in liquid chromatography and capillary electrophoresis enantioseparation of norgestrel with alpha-, beta- and gamma-cyclodextrins. | 2002 Jul 5 |
|
[Capillary electrochromatography for chiral separation and purity testing of pharmaceutical drug substances]. | 2003 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6887923
Each incubation tube contained 12 mM NADPH, 0.1 ml nicotinamide solution, 0.1 ml 0.1 mM MgCl, solution, 0.1 ml 0.1 mM MnCl, solution and 4 ml rabbit microsomal suspension (equivalent to 40 mg protein). The radioactive steroid (5.4 u Ci in 0.05 ml propane-1,2-diol) was added to the tube and the volume made up to 6ml with 0.5 M Tris buffer pH 7.4. The steroid-tissue ratio was 1:400. The metabolism of D-norgestrel was rapid, more than 50% being metabolised within 10 min and more than 80% within 30 min, whereas for the biologically inactive L-norgestrel, only 50% had been metabolised after 30min incubation.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 04:37:25 UTC 2023
by
admin
on
Sat Dec 16 04:37:25 UTC 2023
|
Record UNII |
Z2QG2679YT
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Z2QG2679YT
Created by
admin on Sat Dec 16 04:37:25 UTC 2023 , Edited by admin on Sat Dec 16 04:37:25 UTC 2023
|
PRIMARY | |||
|
m8063
Created by
admin on Sat Dec 16 04:37:25 UTC 2023 , Edited by admin on Sat Dec 16 04:37:25 UTC 2023
|
PRIMARY | Merck Index | ||
|
62929
Created by
admin on Sat Dec 16 04:37:25 UTC 2023 , Edited by admin on Sat Dec 16 04:37:25 UTC 2023
|
PRIMARY | |||
|
DTXSID90892173
Created by
admin on Sat Dec 16 04:37:25 UTC 2023 , Edited by admin on Sat Dec 16 04:37:25 UTC 2023
|
PRIMARY | |||
|
797-64-8
Created by
admin on Sat Dec 16 04:37:25 UTC 2023 , Edited by admin on Sat Dec 16 04:37:25 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
RACEMATE -> ENANTIOMER |
|
||
|
ENANTIOMER -> ENANTIOMER |
|